Dos Santos Ancély Ferreira, Friedmann-Angeli José Pedro
Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany.
EMBO Mol Med. 2024 Nov;16(11):2657-2659. doi: 10.1038/s44321-024-00150-x. Epub 2024 Oct 7.
Cancer cells exhibit a remarkable ability to orchestrate metabolic adaptations to survive and proliferate. Such metabolic adaptations, including carbohydrates, amino acids and lipid metabolism, have been shown to also contribute to the pathological cascade during cancer progression and therapy resistance. Importantly, these adaptations provide a rational for targeted therapies inducing selective cell death. Recently, two studies by Lorito et al (Lorito et al, 2024) and Ackermann et al (Ackermann et al, 2024) published in reported examples of alterations in lipid metabolism that can promote targetable vulnerabilities for tumors with poor prognosis.
癌细胞表现出显著的能力来协调代谢适应以实现存活和增殖。已表明,包括碳水化合物、氨基酸和脂质代谢在内的此类代谢适应,在癌症进展和治疗耐药过程中也会促成病理级联反应。重要的是,这些适应为诱导选择性细胞死亡的靶向治疗提供了理论依据。最近,洛里托等人(洛里托等人,2024年)和阿克曼等人(阿克曼等人,2024年)于2024年发表的两项研究报告了脂质代谢改变的实例,这些改变可促进预后不良肿瘤出现可靶向的脆弱性。